OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
5
Results
Show all
Save search
Copy query
Show results for
Unknown
(4)
Proteomics
(1)
Organisms
Alphavirus
(1)
Anemia
(1)
Archaea
(1)
Bacteria
(1)
Betaherpesvirinae
(1)
Borrelia
(1)
Chlorella vulgaris
(1)
Clostridium perfringens
(1)
Dengue virus
(1)
Enterovirus A71
(1)
Eukaryota
(1)
Hepatitis B virus
(1)
Human alphaherpesvirus 1
(1)
Human betaherpesvirus 5
(1)
Influenza A virus
(1)
Influenza C virus
(1)
Japanese encephalitis virus group
(1)
Kamptonema sp.
(1)
Listeria monocytogenes
(1)
Mammarenavirus
(1)
Miscanthus x giganteus
(1)
Mycobacterium tuberculosis
(1)
Orthoflavivirus
(1)
Panicum virgatum
(1)
Pseudomonas aeruginosa
(1)
Rattus
(1)
Severe acute respiratory syndrome coronavirus 2
(1)
Staphylococcus aureus
(1)
Streptococcus pneumoniae
(1)
Viruses
(1)
Repository
pride
(1)
Tissue
Permanent cell line cell
(1)
Disease
Sleeping sickness
(1)
Technology Type
Mass Spectrometry
(1)
Shotgun proteomics
(1)
Publication Date
2020
(1)
Release Date
2023
(2)
2025
(1)
2022
(1)
Lab affiliation
Division of Biological Chemistry & Drug Discovery School of Life Sciences University of Dundee Dundee DD1 5EH United Kingdom
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Trypanosoma brucei global proteome changes upon suramin exposure
To understand how suramin kills Trypanosoma brucei, we examined the impact on proteome at different timepoints
ORGANISM(S):
Trypanosoma brucei
2020-04-30
|
PXD014215
|
Pride
Trypanosoma brucei
Drug mode of action
Suramin
Cite
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.
Not available
S-EPMC9333998
|
biostudies-literature
Cite
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10957483
|
biostudies-literature
Cite
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC11872607
|
biostudies-literature
Cite
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10156147
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
